"Neoplasm Staging" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Methods which attempt to express in replicable terms the extent of the neoplasm in the patient.
Descriptor ID |
D009367
|
MeSH Number(s) |
E01.789.625
|
Concept/Terms |
Neoplasm Staging- Neoplasm Staging
- Staging, Neoplasm
- Tumor Staging
- Staging, Tumor
- Cancer Staging
- Staging, Cancer
TNM Staging- TNM Staging
- Staging, TNM
- TNM Staging System
- Staging System, TNM
- Staging Systems, TNM
- System, TNM Staging
- Systems, TNM Staging
- TNM Staging Systems
- TNM Classification
- Classification, TNM
- Classifications, TNM
- TNM Classifications
|
Below are MeSH descriptors whose meaning is more general than "Neoplasm Staging".
Below are MeSH descriptors whose meaning is more specific than "Neoplasm Staging".
This graph shows the total number of publications written about "Neoplasm Staging" by people in this website by year, and whether "Neoplasm Staging" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1993 | 1 | 12 | 13 |
1994 | 0 | 13 | 13 |
1995 | 0 | 10 | 10 |
1996 | 0 | 10 | 10 |
1997 | 1 | 16 | 17 |
1998 | 1 | 17 | 18 |
1999 | 2 | 15 | 17 |
2000 | 0 | 32 | 32 |
2001 | 1 | 22 | 23 |
2002 | 0 | 14 | 14 |
2003 | 2 | 24 | 26 |
2004 | 3 | 18 | 21 |
2005 | 3 | 31 | 34 |
2006 | 0 | 34 | 34 |
2007 | 3 | 45 | 48 |
2008 | 2 | 55 | 57 |
2009 | 2 | 43 | 45 |
2010 | 2 | 65 | 67 |
2011 | 4 | 52 | 56 |
2012 | 2 | 55 | 57 |
2013 | 3 | 62 | 65 |
2014 | 4 | 75 | 79 |
2015 | 2 | 68 | 70 |
2016 | 11 | 56 | 67 |
2017 | 4 | 67 | 71 |
2018 | 4 | 55 | 59 |
2019 | 10 | 55 | 65 |
2020 | 2 | 38 | 40 |
2021 | 1 | 33 | 34 |
2022 | 0 | 21 | 21 |
2023 | 0 | 14 | 14 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neoplasm Staging" by people in Profiles.
-
Evaluation of Nationwide Trends in Nodal Sampling Guideline Adherence for Gastric Cancer: 2005-2017. J Surg Res. 2023 11; 291:514-526.
-
Extensive versus focal lymphovascular invasion in squamous cell carcinoma of the cervix: A comprehensive international, multicenter, retrospective clinicopathologic study. Gynecol Oncol. 2023 09; 176:147-154.
-
Preoperative Treatment of Locally Advanced Rectal Cancer. N Engl J Med. 2023 Jul 27; 389(4):322-334.
-
ACR Appropriateness Criteria® Pretreatment Detection, Surveillance, and Staging of Prostate Cancer: 2022 Update. J Am Coll Radiol. 2023 05; 20(5S):S187-S210.
-
Survival of Patients With Neuroblastoma After Assignment to Reduced Therapy Because of the 12- to 18-Month Change in Age Cutoff in Children's Oncology Group Risk Stratification. J Clin Oncol. 2023 06 10; 41(17):3149-3159.
-
Accuracy of models to prognosticate survival after surgery for pancreatic cancer in the era of neoadjuvant therapy. J Surg Oncol. 2023 Aug; 128(2):280-288.
-
Clinicopathologic Characteristics and Prognosis of ERBB2-Low Breast Cancer Among Patients in the National Cancer Database. JAMA Oncol. 2023 04 01; 9(4):500-510.
-
Surgery in Early Metastatic Seminoma: A Phase II Trial of Retroperitoneal Lymph Node Dissection for Testicular Seminoma With Limited Retroperitoneal Lymphadenopathy. J Clin Oncol. 2023 06 01; 41(16):3009-3018.
-
Current Management of Stage IIIA (N2) Non-Small-Cell Lung Cancer: Role of Perioperative Immunotherapy, and Tyrosine Kinase Inhibitors. Thorac Surg Clin. 2023 May; 33(2):189-196.
-
MRI assessment of rectal cancer response to neoadjuvant therapy: a multireader study. Eur Radiol. 2023 Aug; 33(8):5761-5768.